Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Protease Inhibitor Use on Combined Oral Contraceptive Pharmacokinetics and Pharmacodynamics in HIV-positive Women

NCT02531321 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT02531321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02531321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Protease Inhibitor Use on Combined Oral Contraceptive Pharmacokinetics and Pharmacodynamics in HIV-positive Women
Lead sponsor
University of Southern California
Phase
Phase 4
Overall status
Terminated
Start date
August 31, 2015
Completion date
November 1, 2016
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contraception, hiv